FDA
-
-
-
-
-
-
-
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
-
-
-
-
-
-
-
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
-
-
-
-
-
-
-
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
-
-
-
-
-
-
-
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopa
-
-
-
-
-
-
-
Bausch Health Announces Second Quarter 2024 Results
-
-
-
-
-
-
-
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
-
-
-
-
-
-
-
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
-
334,241 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


